Oncology Business Management | Specialty

Economic Factors Affecting Supportive Care

August 23rd 2012

Research is needed to justify the dollar savings achieved by a supportive care program, but it is not clear what should be measured and how studies should be designed to demonstrate this.

Elaine Mardis on Sensitivity to Aromatase Inhibitors

August 20th 2012

Elaine Mardis, from the Genome Institute at Washington University School of Medicine, on Sensitivity to Aromatase Inhibitors

Newly Published Results Show Survival Benefit with Enzalutamide in Prostate Cancer

August 16th 2012

The novel drug enzalutamide (formerly MDV3100) significantly improved overall survival in men with metastatic castrate-resistant prostate cancer (mCRPC).

Myriad Genetics Maintains BRCA1 and BRCA2 Patents, Appellate Court Rules

August 16th 2012

On August 16, the US Federal Circuit Court of Appeals ruled 2-1 to uphold its original decision that Myriad Genetics has the right to hold the patent to the BRCA1 and BRCA2 genes.

Cancer Management Systems: A Path Toward Better Patient Care

August 15th 2012

Oncologists are all faced with the same challenge-delivering the best cancer care possible while reining in rising costs and one answer that many oncologists are looking at is cancer management systems.

Dr. Herbst Explores Molecular Testing in Lung Cancer

August 15th 2012

Dr. Roy S. Herbst, from Yale Cancer Center, Explores Molecular Testing in Lung Cancer

Ranking Value in Cancer Care: Analysis of a "Pathways" Approach

August 13th 2012

Amid a continuing debate over healthcare spending in the United States, the oncology community is growing more introspective about the costs associated with increasingly sophisticated cancer therapeutics.

Urology Practice Management Peer Exchange

August 10th 2012

Investigating Large and Small Urology Practice Intricacies

August 10th 2012

Balancing Quality of Care and Costs in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part I

August 10th 2012

Bone Health Programs in Urology Practices, Part II

August 10th 2012

Introduction to Urologists in Cancer Care Peer Exchange

August 10th 2012

Bone Health Programs in Urology Practices, Part I

August 10th 2012

Management of Oncology Care in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part II

August 10th 2012

Dr. Gandara Discusses Molecular Testing for NSCLC

August 9th 2012

Dr. David Gandara, from University of California, Davis Comprehensive Cancer Center, discusses using the multiplexing assay for patients with non-small cell lung cancer

Tivantinib Achieves Advantage for Patients With HCC

August 9th 2012

Tivantinib has demonstrated statistically significant improvements in time to progression and overall survival versus placebo among patients with unresectable hepatocellular carcinoma.

Dr. Hesketh on Developing Guidelines and Protocols

July 25th 2012

Dr. Paul J. Hesketh, from Lahey Clinic Medical Center, on Developing Guidelines and Protocols

Sipuleucel-T Studies Support Earlier Use, Reveal Potential Biomarker

July 25th 2012

Research presented at ASCO 2012 examined the expanded use of sipuleucel-T, as well as methods to determine which patients might benefit the most from the therapy.